Thousand Hills

Thousand Hills Life Sciences is a biotechnology company dedicated to the discovery and development of novel therapies targeting cellular senescence to treat age-related diseases. Founded by Dr. Jan van Deursen, a pioneer in the field of senolytics, the company leverages foundational insights into the biological mechanisms of aging to create interventions that improve human healthspan. Their research primarily centers on identifying and selectively eliminating senescent cells that contribute to chronic inflammation and tissue dysfunction. By targeting these "zombie cells," Thousand Hills Life Sciences aims to address a broad range of conditions, including fibrotic diseases and metabolic disorders, through a precision medicine approach to aging.